ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 268965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 268965; 2) Community: the network communities that were significantly associated with the response to NSC 268965; 3) Molecule: the relationships between components within communities and NSC 268965; 4) MDR: the compounds that were significantly associated with the NSC 268965.

NSC Compound Enrichment Correlation
NSC 671425 Null 0.0183522248172065 0.29968718
NSC 673824 Null 0.0183522248172065 0.3514896
NSC 681638 Camptothecin Derivative 0.0183522248172065 0.47655589
NSC 697192 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dihydroxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0183522248172065 0.20836302
NSC 700584 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-diselone, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0183522248172065 0.17728739
NSC 723531 Resveratrol-3,5-diacetate 0.0183522248172065 0.079206413
NSC 731981 5'(2',2'-difluoro-2'-deoxycytidine) 5-nitrofurfuryl N-methyl-N-(4-chlorobutyl) phosphoramidate 0.0183522248172065 0.36691715
NSC 754385 1-[bis(4,4'-aminophenyl)methylidenyl]-[3]ferrocenophane 0.0183522248172065 0.55181184
NSC 80103 2,3-Butanediol, 1,4-bis(2-methyl-1-aziridinyl)- (8CI) 0.0183522248172065 0.66212337
NSC 10520 Null 0.0183522248172068 -0.40524099
Total:50  Current:19    [First] [Prev] [Next] [Last]